Gyrus Capital II
Managed by Gyrus Capital
Overview
Gyrus Capital II continues Gyrus Capital’s focus on healthcare and sustainability-related services, with an emphasis on complex corporate carve-outs and entrepreneur-led business transitions. The fund’s first investment was LRE Medical, a provider of development and manufacturing services for point-of-care diagnostic systems, medical devices and life-science instruments.
Founded in 2018, Gyrus Capital is a Geneva-based private equity firm focused on healthcare and services businesses supported by structural growth trends. Its sector coverage includes pharmaceuticals, medtech, life sciences and diagnostics, healthcare services, digital transformation, automation, energy transition and resource efficiency. Gyrus invests through buyouts, significant minority positions with governance rights, and growth capital. The firm focuses on corporate carve-outs and founder- or family-led businesses, working with management teams and an operating network throughout diligence, governance and portfolio development.
Selected investments
- LRE Medical — The fund invested in LRE Medical, a German contract development and manufacturing organization for point-of-care diagnostic systems, medical devices and analytical instruments for life-science applications.
Acquire an interest in Gyrus Capital II
You might be able to acquire a position in Gyrus Capital II. Sign up to explore available positions.
Gauge buyer interest for Gyrus Capital II
Sign up here to anonymously gauge interest in your Gyrus Capital II position.
Do you manage this fund? Get in touch to edit the text here.